Literature DB >> 10322798

[Studies on infection of Helicobacter pylori and their subtypes cagA+ and hspA+ in population living in the areas with high and low incidence of gastric cancer].

L Zhang1, J Ma, K Pan.   

Abstract

OBJECTIVE: To explore the difference in infection of Helicobacter pylori (Hp) and their subtypes cagA+ and hspA+ in the residents living in the areas with high and low incidence of gastric cancer.
METHODS: Immunoglobulin G and A antibodies against Hp and immunoglobulin G antibodies against cagA+ and hspA+ were detected for the residents in Linqu and Cangshan Counties of Shandong Province with enzyme-linked immunosorbent assay (ELISA).
RESULTS: Rate of infection with Hp in the residents in Linqu County, an area with high incidence of gastric cancer, was 73.8 percent, significantly higher than that in Cangshan County (59.9%), an area with low incidence. Rates of infection with Hp cagA+ and hspA+ in the residents in Linqu County were 50.9 and 17.0 percent, respectively, also significantly higher than those in Cangshan County (34.0% and 13.2%, respectively). Sensitivities and specificities of the methods for detecting antibodies against Hp, cagA+ and hspA+ were 92.3, 63.2 and 21.9 percent and 71.0, 80.6 and 95.2 percent, respectively, evaluated with 13C-urea breath teat (13C-UBT). Rate of infection with Hp, especially with Hp cagA+, correlated significantly with the high incidence of gastric cancer.
CONCLUSION: The methods for detecting antibodies against Hp and cagA+ subtype are more sensitive and can be used as better indicators in epidemiological studies on gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10322798

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  1 in total

1.  Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patients.

Authors:  Yong-Liang Zhu; Shu Zheng; Qin Du; Ke-Da Qian; Ping-Chu Fang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.